NEW YORK, Jan. 10, 2017 /PRNewswire/ -- Pomerantz LLP is
investigating claims on behalf of investors of DaVita Inc.
("DaVita" or the "Company") (NYSE: DVA). Such investors
are advised to contact Robert S.
Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
9980.
The investigation concerns whether DaVita and certain of its
officers and/or directors have engaged in securities fraud or other
unlawful business practices.
[Click here to join a class action]
On January 6, 2017, the Wall
Street Journal reported that DaVita had received subpoenas from
federal prosecutors seeking "the production of information related
to charitable premium assistance" in connection with DaVita's ties
to the American Kidney Fund, a charity that helps patients pay for
kidney dialysis.
On this news, DaVita stock fell $2.41, or 3.66%, to close at $63.38 on January 9,
2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los
Angeles, is acknowledged as one of the premier firms in the
areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the
Pomerantz Firm pioneered the field of securities class actions.
Today, more than 80 years later, the Pomerantz Firm continues in
the tradition he established, fighting for the rights of the
victims of securities fraud, breaches of fiduciary duty, and
corporate misconduct. The Firm has recovered numerous
multimillion-dollar damages awards on behalf of class members. See
www.pomerantzlaw.com
CONTACT:
Robert S.
Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-davita-inc---dva-300389015.html
SOURCE Pomerantz LLP